|
Specialties:
Internal Medicine
Oncology
Cancer: Hematology/Oncology
|
General Information:
Gender: Female
Nickname:
Patient Type:
Languages: English
|
| View this doctor's Speakers Bureau bio |
|
Office Locations:
Chao Family Comprehensive Cancer Center
101 The City Drive South, Orange, CA 92868
1.877.UCI.DOCS (1.877.824.3627)
UC Irvine Medical Center, Orange
101 The City Drive South, Orange, CA 92868
1.877.UCI.DOCS (1.877.824.3627)
UC Irvine Breast Health Center
Chao Family Comprehensive Cancer Center, 101 The City Drive South, Orange, CA 92868
1.877.UCI.DOCS (1.877.824.3627)
|
Clinical Interests:
Breast cancer
Immune thrombocytopenic purpura
Chronic lymhocytic leukemia
Low grade lymphoma
ITP & Lymphoma
|
Certifications:
American Board of Internal Medicine, Medical Oncology
|
Professional Positions:
Associate Professor of Medicine, Division of Hematology/Oncology
|
Awards:
Orange County Physician of Excellence-2006
|
Education:
| Medical School: | MGM Medical College, India |
| Internship: | MGM Medical College, India, Internal Medicine |
| Residency: | New York Medical College, Internal Medicine |
| Fellowship: | UC Irvine Medical Center, Hematology, Oncology |
| Residency: | MGM Medical College, India, Anesthesiology |
|
More About Dr:
Recent Publications
(1) Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring chemotherapy response. Breast Cancer Research 2005, 7:279-285 (28 November 2005);
(2) Cerussi A, Hsiang D, Shah N, Mehta RS, Durkin A, Butler J,Tromberg BJ Predicting Response to Breast Cancer Neoadjuvant Chemotherapy using Diffuse Optical Spectroscopy. PNAS published February 28, 2007, 10.1073/pnas.0611058104;
(3) Mehta RS, Schubbert T., Hsiang D, Su M-Y, Carpenter P, Holcombe R, Butler J, Baick C.. High pathological complete remission rate following neoadjuvant taxane, carboplatin and trastuzumab therapy after doxorubicin and cyclophosphamide in Her-2 positive breast cancer patients. Breast Cancer Res Treat 88, 2004 (suppl 1, abst 1110). |
|
